Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 541

1.
2.

Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

Berger WE, Lumry WR, Meltzer EO, Pearlman DS.

Allergy Asthma Proc. 2006 May-Jun;27(3):214-23.

PMID:
16913264
3.

Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.

Devillier P, Roche N, Faisy C.

Clin Pharmacokinet. 2008;47(4):217-30. Review.

PMID:
18336052
4.

Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA.

Clin Exp Allergy. 2004 Jun;34(6):958-64.

PMID:
15196286
5.

Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.

Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.

Clin Ther. 2009 Aug;31(8):1664-87. doi: 10.1016/j.clinthera.2009.08.015. Review.

PMID:
19808127
6.

Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.

Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL.

Int Immunopharmacol. 2005 Dec;5(13-14):1800-8. Epub 2005 Jun 13.

PMID:
16275616
7.

Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.

Bachert C, Maurer M.

Clin Drug Investig. 2010;30(2):109-22. doi: 10.2165/11530930-000000000-00000. Review.

PMID:
20067329
9.

Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.

Anolik R.

Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):683-94. doi: 10.1517/17425250902980187. Review.

PMID:
19473112
10.

Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.

Bachert C, van Cauwenberge P.

Clin Ther. 2007 Sep;29(9):1795-802. Review.

PMID:
18035184
11.

Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.

Ciebiada M, Górska-Ciebiada M, DuBuske LM, Górski P.

Ann Allergy Asthma Immunol. 2006 Nov;97(5):664-71.

PMID:
17165277
12.

Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE.

Int Arch Allergy Immunol. 2011;156(1):1-15. Review.

PMID:
21969990
13.

Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis.

Holmberg K, Tonnel AB, Dreyfus I, Olsson P, Cougnard J, Mesbah K, Devillier P.

Allergy. 2009 Nov;64(11):1663-70. doi: 10.1111/j.1398-9995.2009.02096.x. Epub 2009 Sep 9. Erratum in: Allergy. 2010 Mar;65(3):412.

14.

Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.

Grubbe RE, Lumry WR, Anolik R.

J Investig Allergol Clin Immunol. 2009;19(2):117-24.

16.

Comparative efficacy of levocetirizine, desloratidine and fexofenadine by histamine wheal suppression test.

Dhanya NB, Thasleem Z, Rai R, Srinivas CR.

Indian J Dermatol Venereol Leprol. 2008 Jul-Aug;74(4):361-3.

17.

A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.

Passalacqua G, Canonica GW.

Clin Ther. 2005 Jul;27(7):979-92. Review. Erratum in: Clin Ther. 2005 Oct;27(10):1669.

PMID:
16154477
18.

The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.

Stokes JR, Romero FA Jr, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB.

J Allergy Clin Immunol. 2012 Feb;129(2):409-12, 412.e1-2. doi: 10.1016/j.jaci.2011.11.026. Epub 2011 Dec 22.

PMID:
22196768
20.
Items per page

Supplemental Content

Write to the Help Desk